Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Journal of Molecular and Cellular Cardiology|November 5, 2010
Circulating smooth muscle progenitor cells in arterial remodelingJan-Marcus Daniel, Daniel G SeddingCardiovascular Research|March 19, 2015
Emerging translational approaches to target STAT3 signalling and its impact on vascular diseaseJochen Dutzmann, Jan-Marcus Daniel, Johann Bauersachs, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 26, 2010
Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formationJan-Marcus Daniel, Wiebke Bielenberg, Philipp Stieger, et al.International Journal of Cardiology|April 24, 2017
Systemic application of sirolimus prevents neointima formation not via a direct anti-proliferative effect but via its anti-inflammatory propertiesJan-Marcus Daniel, Jochen Dutzmann, Hannes Brunsch, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 15, 2015
Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima FormationJan-Marcus Daniel, André Prock, Jochen Dutzmann, et al.BMJ Open|April 8, 2022
Effect of intermittent fasting after ST-elevation myocardial infarction on left ventricular function: study protocol of a pilot randomised controlled trial (INTERFAST-MI)Jochen Dutzmann, Kai Knöpp, Zoe Kefalianakis, et al.Basic Research in Cardiology|March 16, 2012
Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formationJan-Marcus Daniel, Jochen Dutzmann, Wiebke Bielenberg, et al.Circulation. Heart Failure|May 2, 2024
Intermittent Fasting After ST-Segment-Elevation Myocardial Infarction Improves Left Ventricular Function: The Randomized Controlled INTERFAST-MI TrialJochen Dutzmann, Zoe Kefalianakis, Florian Kahles, et al.Biological Chemistry|January 23, 2008
FoxO transcription factors in oxidative stress response and ageing--a new fork on the way to longevity?Daniel G SeddingPlos One|September 20, 2017
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injuryJochen Dutzmann, Robert-Jonathan Musmann, Marco Haertlé, et al.Pageof 6